Clinical value of hysteroscopic levonorgestrel intrauterine system suture fixation in treating adenomyosis. [PDF]
Wang J, Gong L, Xin Y, Yuan L, Li G.
europepmc +1 more source
Risks of pelvic inflammatory disease and bacterial vaginosis in adenomyosis patients using levonorgestrel intrauterine device or oral norethindrone. [PDF]
Niu SY, Yi YC, Shih YH, Tseng JJ.
europepmc +1 more source
Hormonal Contraceptives and Migraine Frequency and Severity in Women: A Systematic Review and Meta-Analysis. [PDF]
Alju SK +11 more
europepmc +1 more source
Impact of prior levonorgestrel intrauterine device use at the time of embryo transfer. [PDF]
Vanderhoff A, Lanes A, Ginsburg E.
europepmc +1 more source
Central Pathology Review of Endometrial Hyperplasia and Adenocarcinoma Before and After Treatment With the Levonorgestrel Intrauterine Device-Results From the feMMe Phase 2 Randomized Clinical Trial. [PDF]
Baxter E +5 more
europepmc +1 more source
Treatment Utilization after Uterine Fibroid Diagnosis by Race and Ethnicity. [PDF]
Mitro SD +5 more
europepmc +1 more source
In vitro release testing of levonorgestrel intrauterine systems: Correlation of accelerated release rates in organic/aqueous release media to Hansen Solubility Parameters. [PDF]
Zaman RU +6 more
europepmc +1 more source
The Intrauterine Device: How to Deploy This Strategy in the Molecular World? [PDF]
Johannet P, Friedman CF.
europepmc +1 more source
Comparison of safety and efficacy of hysteroscopic LNG-IUS fixation surgery and conventional LNG-IUS placement in the treatment of adenomyosis: A retrospective cohort study. [PDF]
Li S +8 more
europepmc +1 more source

